acut
fibrin
organ
pneumonia
afop
recent
describ
histolog
pattern
character
presenc
fibrin
ball
within
alveolar
space
term
undifferenti
connect
tissu
diseas
uctd
use
identifi
autoimmun
system
diseas
fulfil
criteria
classifi
definit
connect
tissu
diseas
afop
never
report
associ
uctd
present
report
case
caucasian
femal
dri
cough
progress
dyspnea
eight
month
later
diagnos
organ
pneumonia
base
clinic
histori
radiolog
imag
manifest
raynaud
phenomenon
sicca
syndrom
boot
glove
neuropath
pain
previou
hypothyroid
antinuclear
antibodi
rheumatoid
factor
specif
autoantibodi
neg
salivari
gland
biopsi
electroneuromyiographi
normal
capillaroscopi
show
scleroderma
pattern
capillari
delet
ectasia
experienc
clinic
radiolog
worsen
despit
submit
cyclophosphamid
puls
develop
hemorrhag
die
thoracotomi
pulmonari
specimen
show
histolog
pattern
afop
paper
show
rare
associ
afop
uctd
acut
fibrin
organ
pneumonia
afop
unusu
type
lung
injuri
character
typic
histolog
pattern
recent
describ
whose
main
featur
presenc
intraalveolar
fibrin
form
ball
organ
pneumonia
patchi
distribut
meet
classic
histolog
criteria
bronchiol
obliteran
organ
pneumonia
boop
eosinophil
pneumonia
ep
diffus
alveolar
damag
dad
entiti
describ
beasley
et
al
present
clinic
lung
injuri
seem
two
distinct
pattern
diseas
progress
outcom
acut
fulmin
cours
rapid
progress
death
subacut
chanc
surviv
recoveri
acut
fibrin
organ
pneumonia
afop
may
idiopath
natur
associ
mani
factor
autoimmun
rheumat
diseas
occup
exposur
exot
anim
coal
tungsten
mine
hairspray
alter
immun
statu
longterm
steroid
use
poorli
control
diabet
alcohol
lymphoma
acut
myeloid
leukemia
allogen
hematopoiet
stem
cell
transplant
hiv
infect
pneumocysti
jiroveci
pneumonia
infecti
caus
haemophilu
influenza
acinetobact
baumannii
coronaviru
exposur
drug
abacavir
decitabin
amiodaron
term
undifferenti
connect
tissu
diseas
uctd
use
identifi
autoimmun
system
diseas
fulfil
criteria
classifi
definit
connect
tissu
diseas
ctd
system
lupu
erythematosu
syndrom
system
sclerosi
mix
connect
tissu
diseas
rheumatoid
arthriti
system
vascul
polymyositisdermatomyos
studi
observ
condit
could
progress
diseas
onset
uctd
similar
ctd
peak
middl
year
life
natur
histori
rare
entiti
variabl
high
percentag
patient
uctd
maintain
undifferenti
clinic
cours
evolv
distinct
ctd
wherea
patient
evolv
time
lung
involv
first
clinic
manifest
uctd
rare
report
usual
appear
complic
establish
uctd
six
case
afop
associ
rheumat
diseas
describ
previous
publish
case
afop
uctd
femal
caucasian
psychologist
sought
medic
attent
complain
cough
chest
radiographi
show
chang
attribut
pneumonia
treat
cefuroxim
time
eight
month
progress
dyspnea
associ
initi
diagnosi
pulmonologist
organ
pneumonia
base
clinic
histori
comput
tomograph
ct
find
describ
focal
area
lung
parenchym
infiltr
groundglass
opac
associ
septal
thicken
peripher
distribut
predomin
lower
lobe
figur
b
transbronchi
biopsi
perform
show
scant
fragment
bronchial
wall
adjac
alveolar
collaps
exhibit
minimum
focu
interstiti
inflammatori
infiltr
prescrib
treatment
prednison
mgday
twelv
month
evolut
sinc
onset
symptom
went
rheumatologist
differenti
diagnosi
evalu
occas
pulmonologist
alreadi
search
exclud
tuberculosi
dyspnea
minim
exert
diffus
pain
arm
leg
burn
fingertip
fatigu
sleep
disord
raynaud
phenomenon
rp
xerostomia
xerophthalmia
present
symptomatolog
interrog
physic
examin
posit
person
famili
histori
hashimoto
thyroid
physic
examin
skin
thicken
arthriti
oroscopi
normal
blood
pressur
mmhg
heart
frequenc
beat
per
minut
upon
respiratori
system
examin
basal
crackl
bilater
breath
per
minut
observ
chang
cardiovascular
abdomin
examin
test
request
investig
rheumat
diseas
includ
system
sclerosi
syndrom
vascul
occas
prednison
dose
increas
mgkgday
inflammatori
activ
test
serolog
antibodi
test
demonstr
tabl
evalu
lung
function
pattern
compat
incipi
restrict
ventilatori
disord
observ
evid
inflammatori
activ
crp
alway
neg
esr
increas
autoantibodi
neg
antinuclear
antibodiesana
rheumatoid
factor
antiscl
antirnp
antissa
antissb
canca
except
panca
reagent
patient
present
normocyt
normochrom
anemia
hemoglobin
valu
rang
mgdl
hematocrit
rang
probabl
due
underli
diseas
two
occas
patient
present
lymphopenia
could
indic
diseas
activ
could
relat
steroid
therapi
chlamydia
pneumonia
igg
serolog
reagent
igm
neg
mycoplasma
pneumonia
serolog
neg
exam
allow
exclud
syndrom
neg
antissa
antissb
normal
salivari
biopsi
renal
liver
hormon
function
normal
panoram
nailfold
capillaroscopi
show
presenc
moder
capillari
ectasia
mild
devascular
focal
distribut
describ
welldefin
scleroderma
sd
standard
microangiopathi
consist
system
sclerosi
dermatomyos
overlap
syndrom
scleroderma
compon
figur
given
result
capillaroscopi
presenc
rp
diagnos
system
sclerosi
earli
stage
propos
start
cyclophosphamid
puls
g
howev
three
week
diagnosi
patient
develop
high
fever
degre
dyspnea
rest
requir
hospit
admiss
respiratori
frequenc
incurs
per
minut
arteri
oxygen
tension
mmhg
oxygen
satur
basal
crackl
bilater
third
day
develop
respiratori
failur
requir
ventilatori
support
intens
care
chest
ct
show
interstiti
infiltr
diffus
groundglass
opac
lung
associ
foci
parenchym
densif
predominantli
peripher
air
bronchogram
mild
pleural
thicken
margin
evid
right
lung
basi
apex
small
calcifi
nodul
residu
aspect
scatter
lung
without
pleural
effus
figur
c
observ
echocardiogram
done
exclud
pulmonari
hypertens
pulmonari
arteri
pressur
mmhg
hemocultur
urin
cultur
neg
viru
b
c
serolog
neg
crp
increas
mgdl
moment
pulmonologist
consid
three
possibl
diagnosi
nonspecif
interstiti
pneumonia
pneumonia
caus
pneumocysti
carinii
pneumonia
caus
viru
cmv
adenoviru
herp
fourth
day
underw
open
biopsi
microthoracotomi
consist
pulmonari
segmentectomi
right
middl
lower
lobe
part
materi
sent
investig
fungu
mycobacteria
gener
cultur
present
neg
result
biopsi
reveal
infecti
process
granuloma
histopatholog
examin
show
parenchym
diffus
involv
intraalveolar
fibrin
accumul
form
solid
block
pneumocyt
hyperplasia
interstiti
mild
acut
inflammatori
infiltr
alveolar
septal
edema
congest
intraalveolar
fibroblast
masson
bodi
xantomatososum
accumul
macrophag
typic
pattern
acut
fibrin
organ
pneumonia
afop
figur
e
exclud
infect
etiolog
includ
bacteria
viru
mycobacteria
fungu
receiv
puls
therapi
cyclophosphamid
g
methylprednisolon
g
three
day
despit
treatment
patient
develop
respiratori
failur
pulmonari
hemorrhag
report
case
femal
patient
year
diagnosi
undifferenti
connect
tissu
diseas
uctd
manifest
suggest
system
sclerosi
ssc
raynaud
phenomenon
rp
capillaroscop
pattern
sd
associ
acut
fibrin
organ
pneumonia
afop
difficulti
complet
diagnosi
relat
pulmonari
system
aspect
detail
assess
rheumatologist
specialist
note
presenc
rp
symptom
guid
ssc
diagnosi
raynaud
phenomenon
one
common
symptom
ssc
also
find
rheumat
diseas
like
lupu
rheumatoid
arthriti
syndrom
myositi
overlap
diseas
often
preced
rheumat
diseas
manifest
variabl
period
time
present
time
capillaroscopi
recommend
mandatori
exam
investig
rp
diagnosi
earli
ssc
patient
rp
presenc
capillaroscopi
abnorm
character
scleroderma
pattern
indic
high
specif
posit
predict
valu
diagnosi
ssc
relat
disord
posit
antinuclear
antibodi
test
manifest
strongli
suggest
ssc
possibl
give
diagnosi
base
american
colleg
rheumatolog
criteria
also
patient
skin
characterist
pulmonari
manifest
conclud
diagnosi
uctd
case
report
rheumatolog
acut
fibrin
organ
pneumonia
afop
histolog
pattern
character
intraalveolar
fibrin
accumul
associ
organ
pneumonia
consist
intralumin
loos
connect
tissu
within
alveolar
bronchiol
duct
associ
fibrin
case
histopatholog
studi
patient
show
lung
parenchym
diffus
involv
intraalveolar
fibrin
form
solid
block
pneumocyt
hyperplasia
mild
acut
inflammatori
infiltr
interstitium
alveolar
septal
edema
congest
intraalveolar
fibroblast
masson
bodi
also
report
beasley
et
al
beasley
et
al
note
period
onset
symptom
biopsi
perform
exceed
two
month
among
patient
die
averag
number
day
onset
symptom
death
day
patient
month
pass
onset
initi
symptom
biopsi
death
need
mechan
ventil
mv
signific
paramet
correl
prognosi
case
studi
beasley
et
al
patient
requir
mechan
ventil
die
observ
patient
case
steroid
antibiot
associ
diuret
mechan
ventil
use
treatment
afop
beasley
et
al
therapeut
modal
use
correl
outcom
background
found
yet
ideal
treatment
afop
report
literatur
success
treatment
mycophenol
mofetil
methylprednisolon
prednison
cyclophosphamid
patient
studi
receiv
cyclophosphamid
methylprednisolon
puls
therapi
intens
critic
unit
progress
respiratori
failur
pulmonari
hemorrhag
believ
earli
therapi
institut
could
result
favor
outcom
case
although
studi
still
need
new
entiti
support
understand
clinic
diagnosi
afop
undistinguish
other
lung
injuri
diagnosi
ad
radiolog
aspect
rang
differenti
diagnos
atyp
pneumonia
pulmonari
edema
interstiti
pneumonia
present
current
case
initi
pneumonia
diagnos
accord
clinic
radiograph
aspect
diagnos
organ
pneumonia
op
howev
result
histopatholog
examin
show
posteriorli
afop
standard
diagnosi
afop
essenti
histolog
seri
studi
beasley
et
al
case
patient
transbronchi
biopsi
exclud
studi
sinc
due
local
natur
injuri
kind
biopsi
may
fail
histolog
diagnosi
acut
fibrin
organ
pneumonia
afop
diagnosi
made
larg
biopsi
specimen
quit
certain
otherwis
diagnost
featur
diffus
alveolar
damag
dad
eosinophil
pneumonia
ep
op
histolog
pattern
make
differenti
diagnosi
afop
hyalin
membran
seen
dad
despit
presenc
eosinophil
specimen
never
predomin
ep
although
fibrin
deposit
describ
dad
op
pattern
compris
major
compon
process
regard
associ
autoimmun
rheumat
diseas
afop
beasley
et
al
note
seri
associ
ankylos
spondyl
polymyos
associ
rheumat
diseas
system
lupu
erythematosu
juvenil
dermatomyos
alreadi
describ
literatur
tabl
previou
report
literatur
associ
uctd
afop
first
report
case
rare
associ
may
increasingli
report
literatur
new
terminolog
best
known
biopsi
earli
perform
proper
techniqu
paper
present
rare
combin
acut
fibrin
organ
pneumonia
afop
undifferenti
connect
tissu
diseas
uctd
